Home / Business and Economy / City Therapeutics Files for IPO on Nasdaq
City Therapeutics Files for IPO on Nasdaq
25 Sep
Summary
- City Therapeutics has filed for an Initial Public Offering in the US.
- The company, based in Cambridge, Massachusetts, will list on Nasdaq.
- Goldman Sachs, Jefferies, Stifel, and Oppenheimer are managing the IPO.
Drug developer City Therapeutics has officially filed for an initial public offering in the United States. The company, headquartered in Cambridge, Massachusetts, is preparing to offer new shares to the public.
This move will see City Therapeutics list on the Nasdaq stock exchange, adopting the ticker symbol "CTY."
The underwriting of this significant offering is being managed by a consortium of prominent financial firms. These include Goldman Sachs, Jefferies, Stifel, and Oppenheimer, who will facilitate the sale of shares.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
